Find and Pitch Jounalists, Get Your Story Covered

Tags: brain EMA synendos

	Profile	Recent Articles on Subject
1	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Long-Term Data Support Non-Hormonal Drug for Hot-Flash Management - 3 days ago
2	Brandon Hill Tom's Hardware Senior Editor @ Tom's Hardware. technologyediting	Redalf S6 Screen Extender Review: Dual screens with a twist - 3 days ago Nvidia and MediaTek partnership could make G-Sync gaming monitors more affordable for everyone - 29 days ago Samsung's 57-inch Odyssey Neo G9 DUHD Gaming Monitor U.S. Preorders Open - about 1 year ago
3	Kristen Monaco MedPage Today	Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening - 5 days ago Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? - 6 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 6 months ago Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth - 9 months ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - 11 months ago
4	Lauren Forristal TechCrunch Consumer news reporter. TechCrunch. Consumer NewsTechnology	Kinsome aims to bridge the generation gap with its new app for kids and grandparents - 14 days ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	European Commission grants orphan drug designation for Vivet’s VTX-806 - 14 days ago Serac’s imaging agent marks a breakthrough in endometriosis detection - 3 months ago Synendos receives EMA nod for brain therapy - 8 months ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 14 days ago STAT+: What comes after Wegovy? The quest to eradicate obesity - 9 months ago
7	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 14 days ago STAT+: Startup Laronde merges with another biotech in wake of data integrity issue - 11 months ago
8	Dean Takahashi VentureBeat Obsessed with technology. San Francisco + NYC Technology	Sony Group and Startale unveil Soneium blockchain to accelerate Web3 innovation - 27 days ago Emerge partners with Sony Electronics to bring touch platform to smart TVs - 12 months ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 30 days ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - about 1 month ago Phase 3 Trials of Survodutide for Overweight, Obesity to Begin Recruiting Patients - 11 months ago
10	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Theramex’s Eladynos recommended by NICE for post-menopausal bone disease - 30 days ago

Journalists covering synendos